(CCLD) CareCloud - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock •
CCLD: Software, Services, Management, IT, Solutions, Analytics, Healthcare
CareCloud, Inc. (NASDAQ:CCLD) is a healthcare information technology company offering a comprehensive suite of cloud-based solutions and business services to healthcare providers and hospitals in the United States. The company operates through two primary segments: Healthcare IT and Medical Practice Management. Its product portfolio includes technology-enabled business solutions, cloud-based software, digital health services, healthcare IT professional services, and medical practice management services. Key offerings encompass revenue cycle management, claims clearinghouse, medical coding, credentialing, electronic health records, practice management software, patient experience solutions, business intelligence, healthcare analytics, AI-powered tools like CareCloud cirrusAI, chronic care management, remote patient monitoring, telemedicine, and professional consulting services. The company also provides medical practice management services, including facilities, equipment, support staff, and financial advisory services. Formerly known as MTBC, Inc., CareCloud rebranded in March 2021 and is headquartered in Somerset, New Jersey, with operations dating back to 1999.
From a technical perspective, CCLD is currently trading at $3.12 with a 20-day average volume of 94,100 shares. The stocks short-term trend indicates weakness, with the 20-day SMA at $3.73 and 50-day SMA at $3.55, both above the current price. The 200-day SMA at $2.84 suggests the stock is in a longer-term uptrend but has recently pulled back. The ATR of $0.32 indicates moderate volatility. Fundamental analysis shows a market cap of $52.67M, a forward P/E of 3.68, and a P/S ratio of 0.47, signaling undervaluation relative to peers. However, the negative RoE of -84.15% raises concerns about profitability.
3-Month Forecast: Based on
Additional Sources for CCLD Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CCLD Stock Overview
Market Cap in USD | 27m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2014-07-23 |
CCLD Stock Ratings
Growth 5y | -43.7% |
Fundamental | -38.1% |
Dividend | 0.0% |
Rel. Strength Industry | 21.5 |
Analysts | 4.25/5 |
Fair Price Momentum | 1.24 USD |
Fair Price DCF | 5.17 USD |
CCLD Dividends
No Dividends PaidCCLD Growth Ratios
Growth Correlation 3m | -28% |
Growth Correlation 12m | 72.9% |
Growth Correlation 5y | -85.3% |
CAGR 5y | -16.27% |
CAGR/Max DD 5y | -0.17 |
Sharpe Ratio 12m | -0.73 |
Alpha | -3.14 |
Beta | 4.99 |
Volatility | 171.41% |
Current Volume | 30428.6k |
Average Volume 20d | 108.6k |
As of March 14, 2025, the stock is trading at USD 1.60 with a total of 30,428,600 shares traded.
Over the past week, the price has changed by -24.17%, over one month by -60.40%, over three months by -53.22% and over the past year by +21.21%.
Probably not. Based on ValueRay Fundamental Analyses, CareCloud (NASDAQ:CCLD) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -38.08 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCLD as of March 2025 is 1.24. This means that CCLD is currently overvalued and has a potential downside of -22.5%.
CareCloud has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy CCLD.
- Strong Buy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CCLD CareCloud will be worth about 1.5 in March 2026. The stock is currently trading at 1.60. This means that the stock has a potential downside of -7.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 5.2 | 227.5% |
Analysts Target Price | 4.8 | 200% |
ValueRay Target Price | 1.5 | -7.5% |